Cited 0 times in
Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:39:55Z | - |
dc.date.available | 2023-06-02T00:39:55Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194341 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Amivantamab in combination with lazertinib in patients with atypical epidermal growth factor receptor (EGFR) mutations excluding exon 20 insertion mutations: Initial results from CHRYSALIS-2 | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | B.C. Cho | - |
dc.contributor.googleauthor | Y. Wang | - |
dc.contributor.googleauthor | Y. Li | - |
dc.contributor.googleauthor | L. Wu | - |
dc.contributor.googleauthor | B. Besse | - |
dc.contributor.googleauthor | M.E. Marmarelis | - |
dc.contributor.googleauthor | K. Goto | - |
dc.contributor.googleauthor | J-S. Lee | - |
dc.contributor.googleauthor | S-H. Lee | - |
dc.contributor.googleauthor | Y. Zhang | - |
dc.contributor.googleauthor | J. Neal | - |
dc.contributor.googleauthor | J. Curtin | - |
dc.contributor.googleauthor | J.M. Bauml | - |
dc.contributor.googleauthor | J. Mahoney | - |
dc.contributor.googleauthor | L. Trani | - |
dc.contributor.googleauthor | R.E. Knoblauch | - |
dc.contributor.googleauthor | P. Tomasini | - |
dc.identifier.doi | 10.1016/j.annonc.2022.10.359 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422045501 | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl 9 | - |
dc.citation.startPage | S1566 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1566, 2022-11 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.